Testicular and Pituitary Inclusion Formation in Fragile X Associated Tremor/Ataxia Syndrome

Journal of Urology

Volumn 177, Issue 4, 2007, Pages 1434-1437

  Greco, Claudia M ^a,b   Soontrapornchai, Kultida ^b   Wirojanan, Juthamas ^b   Gould, John E ^b   Hagerman, Paul J ^a   Hagerman, Randi J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ataxia; FMR1 protein; human; Leydig cells; pituitary gland; testes

Indexed keywords

ADENOHYPOPHYSIS; ADULT; ALLELE; ARTICLE; ASTROCYTE; ATAXIA; BRAIN; CASE REPORT; CELL INCLUSION; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISEASE COURSE; FMR1 GENE; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FRAGILE X SYNDROME; GENE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NEUROHYPOPHYSIS; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; SYMPTOM; TESTIS; TREMOR;

AGED; ATAXIA; FATAL OUTCOME; FRAGILE X SYNDROME; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; PITUITARY GLAND; TESTIS;

EID: 33947268037     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.11.097     Document Type: Article

References (20)

1. Dombrowski C., Levesque M.L., Morel M.L., Rouillard P., Morgan K., and Rousseau F. Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11 (2002) 371
2. Rousseau F., Rouillard P., Morel M.L., Khandjian E.W., and Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57 (1995) 1006
3. Sullivan A.K., Marcus M., Epstein M.P., Allen E.G., Anido A.E., Paquin J.J., et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20 (2005) 402
4. Hagerman P.J., and Hagerman R.J. The fragile-X premutation: a maturing perspective. Am J Hum Genet 74 (2004) 805
5. Jacquemont S., Hagerman R.J., Leehey M.A., Hall D.A., Levine R.A., Brunberg J.A., et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. J Am Med Assoc 291 (2004) 460
6. Loesch D.Z., Churchyard A., Brotchie P., Marot M., and Tassone F. Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet 67 (2005) 412
7. Jacquemont S., Leehey M.A., Hagerman R.J., Beckett L.A., and Hagerman P.J. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet 43 (2006) 804
8. VanEsch H., Dom R., Bex D., Salden I., Caeckebeke J., Wibail A., et al. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 13 (2005) 121
9. Brunberg J.A., Jacquemont S., Hagerman R.J., Berry-Kravis E.M., Grigsby J., Leehey M.A., et al. Fragile X premutation carriers: characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol 23 (2002) 1757
10. Greco C., Hagerman R.J., Tassone F., Chudley A.E., DelBigio M.R., Jacquemont S., et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125 (2002) 1760
11. Greco C.M., Berman R.F., Martin R.M., Tassone F., Schwartz P.H., Chang A., et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129 (2006) 243
12. Iwahashi C.K., Yasui D.H., An H.J., Greco C.M., Tassone F., Nannen K., et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 129 (2006) 256
13. Arocena D.G., Iwahashi C.K., Won N., Beilina A., Ludwig A.L., Tassone F., et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet 14 (2005) 3661
14. Tassone F., Hagerman R.J., Garcia-Arocena D., Khandjian E.W., Greco C.M., and Hagerman P.J. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet 41 (2004) e43
15. Louis E., Moskowitz C., Friez M., Amaya M., and Vonsattel J.P. Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study. Mov Disord 21 (2006) 420
16. Haider S.G., Talati J., and Servos G. Ultrastructure of peritubular tissue in association with tubular hyalinization in human testis. Tiss Cell 31 (1999) 90
17. Cherrier M.M., Craft S., and Matsumoto A.H. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl 24 (2003) 568
18. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., and McKinlay J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urology 151 (1994) 54
19. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrin Metab 86 (2001) 724
20. Morley J.E., Kaiser F.E., Perry III H.M., Patrick P., Morley P.M., Stauber P.M., et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46 (1997) 410